The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
# Background Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide. # Objectives To conduct a literature review...
Saved in:
| Main Authors: | Nupur Greene, Lita Araujo, Cynthia Campos, Hannah Dalglish, Sarah Gibbs, Irina Yermilov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2022-10-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.37992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The fungal gut microbiota in pediatric-onset multiple sclerosis
by: Nelson Mok, et al.
Published: (2024-12-01) -
The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
by: Marco Puthenparampil, et al.
Published: (2025-01-01) -
Late onset multiple sclerosis
by: Budimkić Maja, et al.
Published: (2024-01-01) -
Humanistic and Economic Burden of Atopic Dermatitis in Pediatric Patients in Spain: A Systematic Review
by: A. Torrelo Fernández, et al.
Published: (2025-04-01) -
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy
by: Ermelinda De Meo, et al.
Published: (2025-03-01)